Article
Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation.
Thrombosis research - 1 Aug 2013
Colaizzo Donatella, Amitrano Lucio, Guardascione Maria Anna, Tiscia Giovanni Luca, D'Andrea Giovanna, Longo Vittoria A C, Grandone Elvira, Margaglione Maurizio
Abstract excerpt
INTRODUCTION: Although investigation for JAK2 V617F mutation is recommended in patients presenting with splanchnic venous thrombosis (SVT), no specific clinical advice is given to SVT patients presenting without myeloproliferative neoplasms (MPN) and JAK2 V617F mutation. In MPN-free SVT patients, to investigate the clinical outcome, the clinical impact of re-evaluation for the JAK2 V617F mutation, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.